Click to save this for later. You can access it from the navigation bar
The NZKGI and MKGI Submission on the Gene Technology Bill supports the potential benefits of gene technologies while calling for a more cautious, customer‑aligned approach. The submission highlights the value placed on GMO‑free products in key markets and raises concerns that exempting gene editing from regulation could undermine transparency and consumer trust. Both organisations recommend that all gene technologies, including gene editing, be subject to clear oversight and reporting, ensuring innovation can progress without compromising market expectations or long‑term sustainability.
